EuroManganese Ltd. (ASX:EMN) is capturing investor attention by developing a waste recycling operation to extract high purity manganese products for the manufacture of lithium ion batteries.

Antisense Therapeutics (ANP) has submitted its antisense drug for Orphan Drug Designation with the US Food and Drug Administration (FDA), and is seeking similar designation in the European market with its application to the European Medicines Agency (EMA) Committee for Orphan Medicinal Products.

More fertiliser, cheaply available, would see sub-Saharan Africa catch up to more developed countries’ food production, and remove their reliance on food imports.

In a collaboration with multi-sided health platform Bearn, MyFiziq (ASX: MYQ) technology will be accessible to Bearn's 25 million pre-registered users.

Melbourne-based small cap Antisense Therapeutics (ANP) aims to develop antisense drugs for under-researched diseases where there is a clear need for better treatments.

Alexium International Group Limited (ASX: AJX) has announced a breakthrough technology for thermal management in textile and foam-based consumer products.

WhiteHawk secures milestone $5.9 million cybersecurity contract with the US Federal Government!

Western Australian gold exploration and development company Classic Minerals Limited has shifted its focus to preparing its Kat Gap Project for production.